Crescent Biopharma (CBIO) Other financing activities (2015 - 2026)
Crescent Biopharma (CBIO) posted quarterly Other financing activities of $280000.0 for Q2 2026, down 99.84% quarter-over-quarter from $178.9 million in Q4 2025.
Crescent Biopharma (CBIO) Other financing activities (2015 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has reported Other financing activities for 11 consecutive years, with $280000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Other financing activities changed N/A year-over-year to $280000.0; the TTM figure through Jun 2026 stood at $179.2 million (up 3583000.0% YoY), while the FY2025 annual figure was $178.9 million, up 3313719.93% from the prior year.
- Other financing activities eased to $280000.0 in Q2 2026 per CBIO's latest filing, from $178.9 million in the prior quarter.
- Across five years, Other financing activities topped out at $178.9 million in Q4 2025 and bottomed at $500.0 in Q2 2024.
- Historically, Other financing activities has averaged $19.9 million across 4 years, with a median of $20114.0 in 2023.
- Annual changes were most pronounced in 2024 — Other financing activities slumped 97.51% — and 2025, when it increased 2.08%.
- Crescent Biopharma's Other financing activities stood at $999.0 in 2023, then plunged by 49.95% to $500.0 in 2024, then surged by 35774900.0% to $178.9 million in 2025, then tumbled by 99.84% to $280000.0 in 2026.
- Business Quant data shows CBIO's Other financing activities at $280000.0 in Q2 2026, $178.9 million in Q4 2025, and $5000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - |
| 10 | Crescent Biopharma | 1.08 Bn | 904.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 280,000.00 |
| Jun 30, 2026 | 280,000.00 |
| Dec 31, 2025 | 178.88 Mn |
| Dec 31, 2025 | 178.88 Mn |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Jun 30, 2024 | 500.00 |
| Jun 30, 2024 | 500.00 |
| Mar 31, 2024 | 4,898.00 |
| Mar 31, 2024 | 4,898.00 |
| Dec 31, 2023 | 999.00 |
| Dec 31, 2023 | 999.00 |
| Sep 30, 2023 | 61,616.00 |
| Sep 30, 2023 | 61,616.00 |
| Jun 30, 2023 | 20,114.00 |
| Jun 30, 2023 | 20,114.00 |
| Mar 31, 2023 | 33,768.00 |
| Mar 31, 2023 | 33,768.00 |
| Sep 30, 2021 | 20,790.00 |
| Sep 30, 2021 | 20,790.00 |